ATG16L1 and Insulin resistance: A study conducted by Frendo-Cumbo et al. found that ATG16L1-deficient mouse embryonic fibroblasts (MEFs) exhibited insulin resistance, which was attributed to the ubiquitin-proteasome-dependent degradation of IRS1.